淋巴细胞亚种群:在患有免疫性血小板缺血症的患者中,对免疫反应的潜在预测因素
Kateřina Žibřidová1,2, Ondřej Souček3,4, Lenka Kujovská Krčmová5
14th Department of Internal Medicine - Hematology, University Hospital Hradec Králové, Hradec Králové, Czech Republic.
Hematology (Amsterdam, Netherlands)
|January 22, 2024
概括
通过免疫标记物,可以预测免疫血小板缺血症 (ITP) 治疗反应. 较高的抗血小板自身抗体和免疫调节指数 (IRI) 表明ITP患者的结果更差.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 免疫性血小板缺血 (ITP) 是一种自身免疫性疾病,其特征是血小板破坏的增加.
- 目前的ITP治疗指南缺乏预测单个患者对单一疗法的反应的工具.
研究的目的:
- 根据ITP患者对治疗的反应,研究免疫系统的差异.
- 确定潜在的生物标志物,以预测ITP中的治疗结果.
主要方法:
- 评估了35名ITP患者的血清,抗血小板自身抗体和T淋巴细胞子集在12个月内.
- 对治疗有反应的患者和没有反应的患者之间的免疫学参数进行比较.
主要成果:
- 与非响应者相比,响应者显示出显著更高的免疫调节指数 (IRI,CD4+/CD8+T细胞比率) (中位数为2.1对1.5).
- 在治疗前的响应者中观察到较高的抗血小板自身抗体水平 (中位数为58%vs. 20%) 和较低的相对CD8+T细胞计数.
- 这些免疫学参数 (抗血小板自身抗体,CD8+ T细胞,IRI) 是治疗反应的重要预测因素.
结论:
- 免疫学参数,包括抗血小板自身抗体,CD8+T细胞计数和IRI,可以作为ITP的预后工具.
- 这些生物标志物可以使患者分层,并指导ITP组合治疗的选择.
更多相关视频
相关概念视频
01:40Cell-mediated Immune Responses
Overview
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...